98%
921
2 minutes
20
Cell-cell fusion remains the least understood type of membrane fusion process. However, the last few years have brought about major advances in understanding fusion between gametes, myoblasts, macrophages, trophoblasts, epithelial, cancer, and other cells in normal development and in diseases. While different cell fusion processes appear to proceed via similar membrane rearrangements, proteins that have been identified as necessary and sufficient for cell fusion (fusogens) use diverse mechanisms. Some fusions are controlled by a single fusogen; other fusions depend on several proteins that either work together throughout the fusion pathway or drive distinct stages. Furthermore, some fusions require fusogens to be present on both fusing membranes, and in other fusions, fusogens have to be on only one of the membranes. Remarkably, some of the proteins that fuse cells also sculpt single cells, repair neurons, promote scission of endocytic vesicles, and seal phagosomes. In this review, we discuss the properties and diversity of the known proteins mediating cell-cell fusion and highlight their different working mechanisms in various contexts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504885 | PMC |
http://dx.doi.org/10.1083/jcb.201901017 | DOI Listing |
Genetics
September 2025
The University of Texas at Arlington, 701 South Nedderman Drive, Arlington, TX 76019, USA.
Physical interactions between cells can profoundly impact cell fate. A vital cell fate for normal development and homeostasis is programmed cell death. Cells fated to die must be efficiently cleared via phagocytosis, with defects associated with a variety of diseases.
View Article and Find Full Text PDFMol Ther Oncol
September 2025
TUM School of Medicine - Clinical Department of Internal Medicine II, TUM University Hospital, 81675 Munich, Germany.
Recent work has indicated that oncolytic virotherapy leads to immunogenic cell death (ICD) as an important mechanism of action; however, the underlying cell death pathways leading to ICD have been less explored. Our previous data demonstrated that chimeric oncolytic recombinant vesicular stomatitis virus-Newcastle disease virus (rVSV-NDV) has a strong immune-stimulating potential that seems to be mediated by immunogenic syncytial oncolysis. In this work, we aimed to investigate the role of apoptosis and necroptosis in mediating syncytial cell death.
View Article and Find Full Text PDFJ Clin Med
August 2025
Department of Morpho-Functional Sciences I, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
: The epiphyseal vascularization of long bones generates a particular flow pattern that is important for adequate angiogenesis to be achieved. Imaging reveals that vessel development in murine long bone involves the expansion and anastomotic fusion of endothelial buds. Impaired blood flow leads to defective angiogenesis and osteogenesis and downregulation of Notch signaling in endothelial cells.
View Article and Find Full Text PDFJ Med Chem
August 2025
Institute of Biomedicine of the University of Barcelona (IBUB), Universitat de Barcelona, Barcelona 08028, Spain.
Novel antiviral drugs are needed to prepare for infections from influenza A virus (IAV). Here, a series of -[(thiophen-3-yl)methyl]benzamides, which target the hemagglutinin (HA)-mediated fusion process, is reported. The most active compound, , displays a 50% effective concentration (EC) of ∼0.
View Article and Find Full Text PDFMethods Mol Biol
August 2025
Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.
The methods detailed here measure the membrane fusion activity of viral fusion proteins and are optimized for the respiratory syncytial virus (RSV). RSV utilizes a class I fusion protein (F) to facilitate fusion between a viral and cellular membrane to allow viral entry into host cells. This process is carried out with the assistance of the glycoprotein (G), which attaches to the host-cell surface, allowing F to interact with the target cell.
View Article and Find Full Text PDF